Related Experiment Video
Updated: Jun 30, 2025

Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis
Andres R Rettig1, Karuna Ganesh1,2
1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract:
Metastasis arises from cancer cell-intrinsic adaptations and permissive tumor microenvironments (TME) that are distinct across different organs. Deciphering the mechanisms underpinning organotropism could provide novel preventive and therapeutic strategies for patients with cancer. Rogava and colleagues identified Pip4k2c as a driver of liver metastasis, acting by sensitizing cancer cells to insulin-dependent PI3K/AKT signaling, which could be reversed by dual pharmacologic inhibition of PI3K and SGLT2 or a ketogenic diet. The study highlights the importance of tumor microenvironment communication in the context of systemic physiology and points toward potential combination therapies.
Insights
Researchers found Pip4k2c drives liver metastasis by enhancing insulin signaling in cancer cells. This process can be reversed through specific drug combinations or a ketogenic diet, offering new therapeutic avenues.
Area of Science:
- Oncology
- Cancer Biology
- Metabolism
Background:
- Metastasis, the spread of cancer, is influenced by cancer cell adaptations and the tumor microenvironment (TME).
- Understanding organ-specific metastasis (organotropism) is crucial for developing targeted cancer therapies.
- The TME's interaction with systemic physiology significantly impacts cancer progression.
Purpose of the Study:
- To identify key molecular drivers of liver metastasis.
- To elucidate the mechanisms by which cancer cells adapt to specific organ environments.
- To explore potential therapeutic strategies targeting organotropism.
Main Methods:
- Identification of Pip4k2c as a critical factor in liver metastasis.
- Investigation of Pip4k2c's role in mediating insulin-dependent phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling.
- Evaluation of therapeutic interventions including dual PI3K/SGLT2 inhibition and ketogenic diet.
Main Results:
- Pip4k2c was identified as a driver of liver metastasis.
- Pip4k2c sensitizes cancer cells to insulin-dependent PI3K/AKT signaling.
- Dual inhibition of PI3K and SGLT2, or a ketogenic diet, reversed the pro-metastatic effects.
Conclusions:
- Pip4k2c plays a significant role in liver metastasis by modulating cancer cell signaling.
- Targeting metabolic pathways and signaling cascades presents a promising strategy for preventing or treating liver metastasis.
- The study underscores the importance of systemic physiology in cancer progression and highlights potential combination therapies.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer
Cancers Originate from Somatic Mutations in a Single Cell

